BREWIN DOLPHIN LTD - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 254 filers reported holding TG THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$7,353
+7.6%
8500.0%0.00%0.0%
Q1 2019$6,834
+96.1%
8500.0%0.00%
Q4 2018$3,485
-26.8%
8500.0%0.00%
-100.0%
Q3 2018$4,760
-57.4%
8500.0%0.00%0.0%
Q2 2018$11,178
-7.4%
8500.0%0.00%0.0%
Q1 2018$12,070
+73.2%
8500.0%0.00%0.0%
Q4 2017$6,970
-30.8%
8500.0%0.00%0.0%
Q3 2017$10,0738500.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Jetstream Capital LLC 200,000$7,758,0005.97%
Lion Point Capital, LP 609,128$23,628,0004.08%
RA Capital Management 3,342,743$129,665,0002.08%
Ghost Tree Capital, LLC 180,000$6,982,0001.92%
Nicholas Investment Partners, LP 660,964$25,639,0001.61%
ARDSLEY ADVISORY PARTNERS LP 350,000$13,577,0001.60%
SECTORAL ASSET MANAGEMENT INC 414,949$16,096,0001.30%
Spotlight Asset Group, Inc. 75,000$2,909,0001.12%
ACT CAPITAL MANAGEMENT, LLC 55,000$2,134,0001.10%
Pier Capital, LLC 280,486$10,880,0001.09%
View complete list of TG THERAPEUTICS INC shareholders